title: The drug cost gap and the diagnosis-prescription connection.
abstract: Although the rise in pharmacy benefit costs continues to outpace overall medical cost inflation, the gap is narrowing. Employers can improve cost and employee wellness even further with an innovative technique for drug therapy compliance called the Diagnosis-Prescription (Dx-Rx) approach. This article reports results from a 2007 national employer survey on pharmacy benefits and describes how the Dx-Rx innovation can keep patients and their doctors on track when it comes to controlling disease and driving down overall medical costs.
authors.affiliation: Mercer, Houston, TX, USA.
authors.forename: David
authors.initials: D
authors.lastname: Dross
mesh_terms: D003363:Cost Control / Q000379:methods; D003933:Diagnosis; D004059:Diffusion of Innovation; D016527:Drug Costs; D011307:Drug Prescriptions; D006264:Health Benefit Plans, Employee; D019538:Health Care Surveys; D006801:Humans; D007356:Insurance, Pharmaceutical Services; D010349:Patient Compliance